CPN logo
Featured Article: Galanin in Locus Coeruleus-Ventral Tegmental Area Axons
William L. Woolverton, Ph.D.

William L. Woolverton, Ph.D.
CPN Scientific Director
Mentoring and Education Core Leader
Professor, Department of Psychiatry and Human Behavior
Associate Chairman for Research, Department of Psychiatry and Human behavior


The University of Mississippi Medical Center
Division of Neurobiology and Behavior Research
Center for Psychiatric Neuroscience
2500 North State Street, Jackson, MS 39216-4505

Phone: (601) 815-1022
FAX:     (601) 984-5899

Print this page
Contact Dr. Woolverton

Key Laboratory Personnel:
Zhixia Wang, M.D. Instructor
Tess Vasterling Research Technician and Laboratory Manager
Amanda Ledbetter Research Technician
John Dollarhide Research Technician
   

Research Interests

The goal of the Laboratory of Drug Abuse Research is to improve our understanding of the interaction between pharmacological, environmental, and neurochemical variables that control drug abuse. The approach involves combining techniques of in vivo pharmacology with those of behavior analysis to study intravenous self-administration, drug discrimination, and the direct effects of drugs on the behavior of animals. Animal subjects serve as an excellent model for studying the effects of drugs of abuse under controlled laboratory conditions. With regard to pharmacology and neurochemistry, recent research has focused on the roles of D1 and D2 dopamine receptors, and the dopamine transporter, in the abuse of psychomotor stimulants such as cocaine. With regard to the role of the environment, current efforts are concentrated on understanding how environmental conditions determine the choice that animals (and humans) make among drug taking and other available activities.

Selected Publications

Fantegrossi, W.E., Woolverton, W.L., Winger, G., Coop, A. and Woods, J.H.: Reinforcing and discriminative stimulus effects of l-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys. Drug Alc. Depend. 77: 161-168, 2005.

Anderson, K.G. and Woolverton, W.L.: Effects of clomipramine on self-control choice in Lewis and Fischer 344 rats. Pharmacology Biochemistry and Behavior 80: 387-393, 2005.

Wee, S., Anderson, K.G., Baumann, M.H., Rothman, R.B., Blough, B.E. and Woolverton, W.L.: Relationship between the serotonergic activity and the reinforcing effects of a series of amphetamine analogs. J. Pharmacol. Exp. Ther. 313: 848-854, 2005.

Rothman, R.B., Blough, B.E., Woolverton, W.L., Anderson, K.G., Negus, S.S., Mello, N.K., Roth, B.L. and Baumann, M.H.: Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration. J. Pharmacol. Exp. Ther. 313: 1361-1369, 2005.

Wee, S., Carroll, F.I., and Woolverton, W.L.: A reduced rate of in vivo dopamine transporter binding is associated with lower relative reinforcing efficacy of stimulants. Neuropsychopharmacology, in press.

Wee, S., Wang, Z., He, R., Zhou, J., Kozikowski, A.P. and Woolverton, W.L.: Role of increased noradrenergic neurotransmission in drug self-administration. Drug Alc. Depend., in press.